Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4666 to 4680 of 7691 results

  1. Early mobilisation and optimum positioning of people with acute stroke: How safe and effective is very early mobilisation delivered by appropriately trained healthcare professionals after stroke?

    Recommendation ID NG128/07 Question Early mobilisation and optimum positioning of people with acute stroke: How safe and effective is very

  2. How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period?

    Recommendation ID CG192/2 Question How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period? Any explanatory

  3. Intrauterine fetal death after previous caesarean birth: How should labour be induced in women with intrauterine fetal death who have had a previous caesarean birth, and who choose to be induced?

    Recommendation ID NG207/04 Question Intrauterine fetal death after previous caesarean birth: How should labour be induced in women with

  4. Identifying barriers and enablers to using the views and experiences of people who use services to improve services:- What are the barriers and enablers to gathering, synthesising and applying data on the views and experiences of people who use services for the purposes of service improvement?

    Recommendation ID NG86/3 Question Identifying barriers and enablers to using the views and experiences of people who use services to improve

  5. Identifying employees at risk of poor mental wellbeing: What tools (for example, wellbeing surveys) can be used to identify employees at risk of poor mental wellbeing rather than mental ill health?

    Recommendation ID NG212/07 Question Identifying employees at risk of poor mental wellbeing: What tools (for example, wellbeing surveys)

  6. Identifying infection in women with preterm prelabour rupture of membranes (P-PROM):- What is the diagnostic accuracy of serial C-reactive protein testing to identify chorioamnionitis in women with P-PROM?

    Recommendation ID NG25/2 Question Identifying infection in women with preterm prelabour rupture of membranes (P-PROM):- What is the diagnostic

  7. Identifying older people at high risk:- In the UK, what are the most effective ways to identify older people who at risk of a decline in their independence and mental wellbeing?

    Recommendation ID NG32/2 Question Identifying older people at high risk:- In the UK, what are the most effective ways to identify older

  8. Image guidance in the reduction of displaced distal radius fractures:- For patients with displaced fractures of the distal radius, is manipulation with real-time image guidance more clinically and cost effective than manipulation without real-time image guidance?

    Recommendation ID NG38/3 Question Image guidance in the reduction of displaced distal radius fractures:- For patients with displaced fractures

  9. Imaging in the diagnostic pathway for women with ovarian cancer:- Large multicentre case–control studies should be conducted to compare the accuracy of CT versus MRI for staging and for predicting optimal cytoreduction in women with ovarian cancer.

    Recommendation ID CG122/3 Question Imaging in the diagnostic pathway for women with ovarian cancer:- Large multicentre case–control studies

  10. Imaging of ankle fractures:- Is CT scanning in addition to initial plain film X-ray clinically effective and cost effective for planning surgical treatment of unstable/displaced ankle fractures compared with plain film X-ray alone?

    Recommendation ID NG38/1 Question Imaging of ankle fractures:- Is CT scanning in addition to initial plain film X-ray clinically effective

  11. What are the effective forms of immobilisation for people with MSCC?

    Recommendation ID NG234/2 Question What are the effective forms of immobilisation for people with MSCC? Any explanatory notes(if

  12. What is the effectiveness and cost effectiveness of immunotherapy in people with stage IIIA-N2 non-small-cell lung cancer following multimodality treatment including surgery?

    Recommendation ID NG122/1 Question What is the effectiveness and cost effectiveness of immunotherapy in people with stage IIIA-N2 non-small-cell